The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

People

Dr Katherine Gibney

Dr Katherine Gibney

Dr Katherine Gibney

(03) 9035 3958 | [email protected]

Position:
NHMRC early career fellow
Theme(s):
Antimicrobial Resistance and Healthcare Associated Infections, Enteric infections, Viral Infectious Diseases, Dengue, Emerging Infections
Discipline(s):
Clinical Research, Epidemiology, Indigenous Health, Public Health
Unit(s):
Doherty Directorate, Victorian Infectious Diseases Reference Laboratory (VIDRL), Victorian Infectious Diseases Service (VIDS)
Lab Group(s):
McVernon Group, Tong Group

Dr Katherine Gibney is an infectious diseases physician, public health physician and medical epidemiologist. She has a particular interest in infections in immigrants and returned travellers, vector-borne diseases and gastrointestinal infections, and Indigenous health. Katherine has an appointment in Communicable Disease Epidemiology and Surveillance, Victorian Department of Health. She completed a PhD at Monash University examining the burden of selected infectious diseases in Australia and the national infectious diseases surveillance system. She acts as a disease and country expert for the Global Burden of Disease Study.

  • Key Achievements
    • Katherine graduated from medicine in 2001 and received a Masters of Public Health in 2007. She completed the Epidemic Intelligence Service (EIS) program between 2009 and 2011 – a two-year applied epidemiology fellowship in the arboviral diseases branch of the US Centers for Disease Control (CDC). She completed infectious diseases training (FRACP) in 2010 and public health training (FAFPHM) in 2015. She was awarded a PhD from Monash University in 2016.

    Publications
    Loading ORCID data...
    Research Groups
    • McVernon Group

      Jodie McVernon’s group uses established and emerging biostatistical, epidemiologic and modelling methods to address infectious diseases questions of public health relevance. We bring a suite of collaborators from animal health and ecology to provide a ‘One Health’ perspective on emerging human pathogens.


      Lab Team

    • Tong Group

      Steve’s group conducts clinical trials to optimise the treatment of infections due to methicillin-resistant Staphylococcus aureus and other bacterial pathogens. He also investigates the epidemiology and genomics of streptococcal infections, hepatitis B, influenza, and antimicrobial resistance in Australian Indigenous communities.


      Lab Team